[1]
|
Fazeli, M.S., Khaychuk, V., Wittstock, K., et al. (2021) Rheumatoid Arthritis-Associated Interstitial Lung Disease: Epi-demiology, Risk/Prognostic Factors, and Treatment Landscape. Clinical and Experimental Rheumatology, 39, 1108-1118.
https://doi.org/10.55563/clinexprheumatol/h9tc57
|
[2]
|
Ellman, P. and Ball, R.E. (1948) “Rheumatoid Disease” with Joint and Pulmonary Manifestations. British Medical Journal, 2, 816-820. https://doi.org/10.1136/bmj.2.4583.816
|
[3]
|
Dai, Y., Wang, W., Yu, Y. and Hu, S. (2021) Rheumatoid Arthri-tis-Associated Interstitial Lung Disease: An Overview of Epidemiology, Pathogenesis and Management. Clinical Rheu-matology, 40, 1211-1220.
https://doi.org/10.1007/s10067-020-05320-z
|
[4]
|
Li, L., Liu, R., Zhang, Y., et al. (2020) A Retrospective Study on the Predictive Implications of Clinical Characteristics and Therapeutic Management in Patients with Rheumatoid Arthri-tis-Associated Interstitial Lung Disease. Clinical Rheumatology, 39, 1457-1470. https://doi.org/10.1007/s10067-019-04846-1
|
[5]
|
Hyldgaard, C., Hilberg, O., Pedersen, A.B., et al. (2017) A Pop-ulation-Based Cohort Study of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Comorbidity and Mortality. Annals of the Rheumatic Diseases, 76, 1700-1706.
https://doi.org/10.1136/annrheumdis-2017-211138
|
[6]
|
Yunt, Z.X. and Solomon, J.J. (2015) Lung Disease in Rheumatoid Arthritis. Rheumatic Disease Clinics, 41, 225-236.
|
[7]
|
Demedts, M. and Costabel, U. (2002) ATS/ERS International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. European Respiratory Journal, 19, 794-796.
https://doi.org/10.1183/09031936.02.00492002
|
[8]
|
Chun, M.P., Park, M.S., Oh, I.J., et al. (2020) Safety and Ef-ficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients. Advances in Therapy, 37, 2303-2316.
https://doi.org/10.1007/s12325-020-01328-8
|
[9]
|
焦桐. 类风湿关节炎相关间质性肺病中医证候特征及肠道、舌苔菌群分析[D]: [硕士学位论文]. 天津: 天津中医药大学, 2022.
|
[10]
|
Raghu, G., Remy-Jardin, M., Myers, J.L., et al. (2018) Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine, 198, e44-e68. https://doi.org/10.1164/rccm.201807-1255ST
|
[11]
|
Travis, W.D., Costabel, U., Hansell, D.M., et al. (2013) An Of-ficial American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine, 188, 733-748.
https://doi.org/10.1164/rccm.201308-1483ST
|
[12]
|
Bendstrup, E., Møller, J., Kronborg-White, S., et al. (2019) In-terstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians. Journal of Clinical Medicine, 8, Arti-cle No. 2038. https://doi.org/10.3390/jcm8122038
|
[13]
|
Doyle, T.J., Hunninghake, G.M. and Rosas, I.O. (2012) Subclinical Interstitial Lung Disease: Why You Should Care. American Journal of Respiratory and Critical Care Medi-cine, 185, 1147-1153.
https://doi.org/10.1164/rccm.201108-1420PP
|
[14]
|
Afeltra, A., Zennaro, D., Garzia, P., et al. (2006) Prevalence of Interstitial Lung Involvement in Patients with Connective Tissue Diseases Assessed with High-Resolution Computed Tomography. Scandinavian Journal of Rheumatology, 35, 388-394. https://doi.org/10.1080/03009740600844381
|
[15]
|
Lee, H.-K., Kim, D.S., Yoo, B., et al. (2005) Histopathologic Pattern and Clinical Features of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Chest, 127, 2019-2027. https://doi.org/10.1378/chest.127.6.2019
|
[16]
|
Brown, K.K. (2007) Rheumatoid Lung Disease. Proceedings of the American Thoracic Society, 4, 443-448.
https://doi.org/10.1513/pats.200703-045MS
|
[17]
|
申明. 类风湿关节炎相关肺间质病变的危险因素、临床和影像学特点[J]. 影像研究与医学应用, 2019, 3(12): 87-88.
|
[18]
|
韩雪兰. 类风湿关节炎合并间质性肺疾病的临床、影像学和肺功能分析[D]: [硕士学位论文]. 长春: 吉林大学, 2016.
|
[19]
|
Wang, T., Zheng, X.-J., Liang, B.-M. and Liang, Z.-A. (2015) Clinical Features of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Scientific Reports, 5, Article No. 14897. https://doi.org/10.1038/srep14897
|
[20]
|
Ascherman, D.P. (2010) Interstitial Lung Disease in Rheumatoid Arthritis. Current Rheumatology Reports, 12, 363-369.
https://doi.org/10.1007/s11926-010-0116-z
|
[21]
|
Salaffi, F., Manganelli, P., Carotti, M. and Baldelli, S. (2000) The Differing Patterns of Subclinical Pulmonary Involvement in Connective Tissue Diseases as Shown by Application of Factor Analysis. Clinical Rheumatology, 19, 35-41.
|
[22]
|
Kaarteenaho, R. (2013) The Current Position of Surgical Lung Biopsy in the Diagnosis of Idiopathic Pulmonary Fibrosis. Respiratory Research, 14, Article No. 43. https://doi.org/10.1186/1465-9921-14-43
|
[23]
|
Raghu, G., Mageto, Y.N., Lockhart, D., et al. (1999) The Accuracy of the Clinical Diagnosis of New-Onset Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Disease: A Prospec-tive Study. Chest, 116, 1168-1174.
https://doi.org/10.1378/chest.116.5.1168
|
[24]
|
Arnett, F.C., Edworthy, S.M., Bloch, D.A., et al. (1988) The Amer-ican Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis & Rheuma-tism, 31, 315-324.
https://doi.org/10.1002/art.1780310302
|
[25]
|
Aletaha, D., Neogi, T., Silman, A.J., et al. (2010) 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League against Rheumanism Collabo-rative Initiative. Annals of the Rheumatic Diseases, 69, 1580-1588. https://doi.org/10.1136/ard.2010.138461
|
[26]
|
Huppmann, P., Sczepanski, B., Boensch, M., et al. (2012) Effects of Inpatient Pulmonary Rehabilitation in Patients with Interstitial Lung Disease. European Respiratory Journal, 42, 444-453.
https://doi.org/10.1183/09031936.00081512
|
[27]
|
黄嘉明. 类风湿关节炎相关间质性肺疾病的临床特征和危险因素分析[D]: [硕士学位论文]. 广州: 广州医科大学, 2021.
|
[28]
|
Semenzato, G., Adami, F., Maschio, N. and Agos-tini, C. (2000) Immune Mechanisms in Interstitial Lung Disease. Allergy, 55, 1103-1120. https://doi.org/10.1034/j.1398-9995.2000.00127.x
|
[29]
|
左婷, 李向培. 结缔组织病肺间质纤维化治疗进展[J]. 安徽医药, 2015(5): 821-825.
|
[30]
|
Saravanan, V. and Kelly, C.A. (2006) Drug-Related Pulmonary Problems in Patients with Rheumatoid Arthritis. Rheumatology, 45, 787-790. https://doi.org/10.1093/rheumatology/kel075
|
[31]
|
周雯怡, 杨雅竹, 谢敏, 田雨, 苏励. 类风湿关节炎肺间质病变特点及中西医治疗进展[J]. 医学研究杂志, 2022, 51(10): 20-23.
|
[32]
|
Hadjinicolaou, A.V., Nisar, M.K., Bhagat, S., et al. (2011) Non-Infectious Pulmonary Complications of Newer Biological Agents for Rheumatic Diseases—A Systematic Literature Review. Rheumatology, 50, 2297-2305.
https://doi.org/10.1093/rheumatology/ker289
|
[33]
|
Huang, Y., Lin, W., Chen, Z., et al. (2019) Effect of Tumor Ne-crosis Factor Inhibitors on Interstitial Lung Disease in Rheumatoid Arthritis: Angel or Demon. Drug Design, Develop-ment and Therapy, 13, 2111-2125.
https://doi.org/10.2147/DDDT.S204730
|
[34]
|
MacIsaac, J., Siddiqui, R., Jamula, E., et al. (2018) Systematic Re-view of Rituximab for Autoimmune Diseases: A Potential Alternative to Intravenous Immune Globulin. Transfusion, 58, 2729-2735. https://doi.org/10.1111/trf.14841
|
[35]
|
卜祥伟, 张红红, 张建萍, 等. 类风湿关节炎的中医药研究进展[J]. 环球中医药, 2019, 12(2): 297-303.
|
[36]
|
Demedts, M., Behr, J., Buhl, R., et al. (2005) High-Dose Acetylcys-teine in Idiopathic Pulmonary Fibrosis. New England Journal of Medicine, 353, 2229-2242. https://doi.org/10.1056/NEJMoa042976
|
[37]
|
Bongartz, T., Nannini, C., Medina-Velasquez, Y.F., et al. (2010) In-cidence and Mortality of Interstitial Lung Disease in Rheumatoid Arthritis: A Population-Based Study. Arthritis & Rheumatology, 62, 1583-1591.
https://doi.org/10.1002/art.27405
|